FDA approves first drug for treatment of peanut allergy for children

January 31, 2020 FDA

FDA approves first drug for treatment of peanut allergy for children
Treatment with this product may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older.

Previous Article
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to

The U.S. Food and Drug Administration and the Federal Trade Commission signed a joint statement regarding e...

Next Article
FDA launches mobile-friendly database with information on life-saving HIV drugs as part of ongoing mission to empower the public through inc
FDA launches mobile-friendly database with information on life-saving HIV drugs as part of ongoing mission to empower the public through inc

FDA launches an interactive database that will offer a wealth of critical information about antiretrovirals...